-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
-
Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study
Study tests combination of taxanes with an angiogenesis inhibitor in search for better outcomes for patients with advanced KRAS-mutated NSCLC.
-
Novel Targets and Therapies: KEAP1- and NFE2L2-Mutant Squamous Cell Lung Cancer
During an interview with ILCN, Drs. Paul Paik and Jonathan Reiss discuss the implications of KEAP1 and NFE2L2 mutations in NSCLC.
-
Management of Recurrences after Stereotactic Ablative Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer
Practical aspects of clinically managing operable SABR patients are important for the long-term care of this unique population.
-
Role of Liquid Biopsy in the Clinic Growing
Lung cancer specialists are slowly being faced with the challenge of how to balance the benefits of next-generation tumor tissue testing against those of liquid biopsy in the clinic. During the 2021 International Society of Liquid Biopsy (ISLB) Congress, Natasha Leighl, MD, of Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada, provided attendees with…
-
Need for Molecular Nursing Increasing
Nurses are an essential part of the revolution of personalized care occurring in oncology. During the 2021 International Society of Liquid Biopsy (ISLB) Congress, Allison Gittens, BSN, RN, OCN, a nurse navigator in thoracic oncology at Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, discussed the role of nurses in educating about and advocating for…
-
WHO, IAEA Publish Updated Guidance on Procurement of Radiotherapy Equipment
To increase access to radiotherapy worldwide, new guidance from the WHO and IAEA includes a prioritized list of medical devices for cancer management.
-
PREMER Results: A Q&A With Dr. Núria Rodriguez de Dios
Dr. Rodriguez de Dios talks with ILCN about the implications of the PREMER study, a phase III trial comparing PCI with and without hippocampal avoidance in SCLC.
-
Multidisciplinary Tumor Boards: Six Eyes See More than Two
See how specialists in France use MTBs to develop the most beneficial treatment strategies for patients and to decrease inequity in cancer care.
-
Unplanned Hospital Care in Patients With NSCLC
Study findings suggest that a significant number of unplanned hospital visits for patients with lung cancer might be avoidable.
-
Predicting Early Weight Loss in Radiotherapy
Study shows emerging techniques may improve prognostic and predictive models in identifying patients at risk for early weight loss.
View ILCN Archives
Provider Resources
Popular Articles